Share on LinkedInShare on LinkedIn

ARTICLE · 17 JUNE 2020

Patenting proteins: an Australian perspective

The level of disclosure required to support & enable a claim to a polypeptide will depend on several factors discussed here.

AustraliaIntellectual Property

Biological molecules, including polypeptides and, in some cases, nucleic acids, can be patented under Australian law. The level of disclosure that is required to support and enable a claim to a polypeptide will depend on several factors, including:

  1. the identity of the person skilled in the art;
  2. the information disclosed in the specification;
  3. the function of the polypeptide; and
  4. the specific sequence being claimed.

This article briefly describes how each of these factors contributes to the determination of a claim's scope under Australian practice.

The person skilled in the art

In considering whether a claim is sufficiently enabled, the Australian Patent Office will ask:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Shelston IP ranked one of Australia's leading Intellectual Property firms in 2015.

See more popular content from